NCT00284154View on ClinicalTrials.gov

Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

November 30, 2009

Conditions
Carcinoma, Small CellLung Cancer
Interventions
DRUG

Vinflunine

320mg/m2 every 21 days as a 15-20 minute infusion

Trial Locations (3)

33901

Florida Cancer Specialists, Fort Myers

37023

Tennessee Oncology, PLLC, Nashville

45242

Oncology Hematology Care, Cincinnati

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER

NCT00284154 - Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter